Laronde Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 116

Employees

  • Latest Deal Type
  • M&A

Laronde General Information

Description

Developer of eRNA-based therapeutics intended to make more predictable and impactful medicines for the world. The company's Endless RNA is a uniquely engineered RNA that can be programmed to express diverse proteins inside the body, also it is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery, enabling doctors and medical firms to make new therapeutics that will become essential medicines of the future.

Contact Information

Website
www.laronde.bio
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 55 Cambridge Parkway
  • Suite 800E
  • Cambridge, MA 02142-1234
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Sail Biomedicines
Vertical(s)
Life Sciences
Corporate Office
  • 55 Cambridge Parkway
  • Suite 800E
  • Cambridge, MA 02142-1234
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Laronde Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 19-Oct-2023 Completed Generating Revenue
3. Early Stage VC (Series B) 28-Jul-2021 Completed Startup
2. Early Stage VC (Series A1) 30-Mar-2021 $19.8M $39.8M Completed Startup
1. Early Stage VC (Series A) 30-Sep-2019 $20M $20M Completed Startup
To view Laronde’s complete valuation and funding history, request access »

Laronde Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A-1
Series A 10,768,827 $0.001000 $1 $1 1x $1 18.96%
To view Laronde’s complete cap table history, request access »

Laronde Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of eRNA-based therapeutics intended to make more predictable and impactful medicines for the world. The compan
Drug Discovery
Cambridge, MA
116 As of 2022

Niel, Belgium
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Laronde Competitors (4)

One of Laronde’s 4 competitors is eTheRNA, a Venture Capital-Backed company based in Niel, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
eTheRNA Venture Capital-Backed Niel, Belgium
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Ionis Pharmaceuticals Corporate Backed or Acquired Carlsbad, CA
Moderna Formerly VC-backed Cambridge, MA
To view Laronde’s complete competitors history, request access »

Laronde Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Laronde Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250051386-A1 Compositions and methods for purifying polyribonucleotides Pending 22-Dec-2021
FR-870078-A Further training in the manufacture of spectacle frames Inactive 30-Oct-1940
FR-854226-A Manufacturing process of plastic spectacle elements Inactive 24-Dec-1938
FR-853948-A Improvements to so-called "ice" or claw glasses Inactive 26-Nov-1938
FR-814530-A Improvements to plastic glasses Inactive 27-Feb-1936 G02C5/02
To view Laronde’s complete patent history, request access »

Laronde Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Laronde Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altitude Life Science Ventures Venture Capital Minority
BlackRock Asset Manager Minority
CPP Investments Limited Partner Minority
Federated Kaufmann Fund Mutual Fund Minority
Fidelity Management & Research Company Asset Manager Minority
You’re viewing 5 of 12 investors. Get the full list »

Laronde Acquisitions (1)

Laronde’s most recent deal was a Merger of Equals with Sail Biomedicines. The deal was made on 19-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sail Biomedicines 19-Oct-2023 Merger of Equals Biotechnology
To view Laronde’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Laronde FAQs

  • When was Laronde founded?

    Laronde was founded in 2017.

  • Where is Laronde headquartered?

    Laronde is headquartered in Cambridge, MA.

  • What is the size of Laronde?

    Laronde has 116 total employees.

  • What industry is Laronde in?

    Laronde’s primary industry is Drug Discovery.

  • Is Laronde a private or public company?

    Laronde is a Private company.

  • What is Laronde’s current revenue?

    The current revenue for Laronde is .

  • How much funding has Laronde raised over time?

    Laronde has raised $480M.

  • Who are Laronde’s investors?

    Altitude Life Science Ventures, BlackRock, CPP Investments, Federated Kaufmann Fund, and Fidelity Management & Research Company are 5 of 12 investors who have invested in Laronde.

  • Who are Laronde’s competitors?

    eTheRNA, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Moderna are competitors of Laronde.

  • When was Laronde acquired?

    Laronde was acquired on 19-Oct-2023.

  • Who acquired Laronde?

    Laronde was acquired by Sail Biomedicines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »